Facebook
Twitter
Telegram
Report an ErrorSummit Therapeutics Financial Ratios 2011-2024 | SMMT
Annual Financial Ratios Summit Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.6 | -3.6 | -4.1 | -7.9 | 19.7 | -79.6 | -29.6 | -16.0 | - | - | - | - | - |
P/S |
- | 405.9 | 199.5 | 485.1 | 3.4 | 22.3 | 274.7 | - | - | - | - | - | - |
EPS |
-1.0 | -0.4 | -0.7 | -0.8 | -0.9 | -2.0 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
2.29 B | 475 M | 319 M | 374 M | 153 M | 854 M | 842 M | 396 M | 6.67 M | 3.08 M | 2.41 M | 2.34 M | 2.24 M |
EBITDA per Share |
-0.98 | -0.37 | -0.65 | -0.76 | 0.111 | -0.231 | -0.493 | -0.497 | - | - | - | - | - |
EV/EBITDA |
-1.7 | -264.5 | 16.7 | -51.4 | -24.9 | -12.5 | - | - | - | - | - | ||
PEG |
0.02 | 0.02 | 0.02 | -2.44 | -0.11 | 1.24 | -5.0 | 2.93 | - | - | - | - | - |
P/B |
28.8 | 2.3 | 4.3 | 5.3 | 3.5 | 57.5 | -181.2 | 13.0 | - | - | - | - | - |
P/CF |
-29.1 | -6.9 | -5.0 | -8.7 | -5.5 | -37.4 | 52.5 | -15.9 | - | - | - | - | - |
ROE % |
-791.49 | -62.20 | -106.39 | -66.32 | 17.69 | -72.21 | 611.82 | -80.86 | - | - | - | - | - |
ROA % |
-303.00 | -11.86 | -78.15 | -51.41 | 12.59 | -13.21 | -56.86 | -68.14 | - | - | - | - | - |
ROCE % |
-784.70 | -56.92 | -103.48 | -66.95 | 14.84 | -30.83 | -91.12 | -94.55 | - | - | - | - | - |
Current Ratio |
1.6 | 1.2 | 3.8 | 4.4 | 3.6 | 1.9 | 3.1 | 6.5 | - | - | - | - | - |
DSO |
- | 469.3 | 181.1 | 185.0 | 105.6 | 133.4 | 727.1 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | 84948.9 | 23349.4 | - | - | - | - | - | - | - |
Operating Cycle |
- | 469.3 | 181.1 | 185.1 | 105.6 | 133.4 | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 469.3 | 181.1 | 185.1 | -84843.4 | -23216.0 | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Summit Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.06 | - | -0.03 | -0.02 | -1.43 | - | -0.1 | -0.12 | -0.15 | - | -0.2 | -0.27 | -0.21 | - | -0.26 | -0.23 | -0.09 | - | -0.2 | -0.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.06 | - | - | - | -1.42 | - | -0.08 | -0.09 | -0.16 | - | -0.19 | -0.26 | -0.2 | - | -0.25 | -0.23 | -0.14 | - | -0.18 | -0.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-153.44 | -440.04 | -456.08 | -450.73 | -471.11 | -81.95 | -101.11 | -104.22 | -91.98 | -66.76 | -89.09 | -92.26 | -91.05 | -49.28 | -57.54 | -43.46 | -39.57 | -23.60 | -23.60 | -15.34 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-50.26 | -228.72 | -242.48 | -246.52 | -257.84 | -49.66 | -64.89 | -66.36 | -65.61 | -44.43 | -61.74 | -63.82 | -61.95 | -38.20 | -44.80 | -34.08 | -19.17 | -6.60 | -6.60 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-150.33 | -436.24 | -448.96 | -441.05 | -452.58 | -71.85 | -90.90 | -97.23 | -92.37 | -65.19 | -86.52 | -88.79 | -88.25 | -52.40 | -60.42 | -47.11 | -43.26 | -23.49 | -23.49 | -15.48 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.3 | 1.6 | 1.8 | 2.0 | 2.1 | 1.2 | 7.0 | 2.2 | 2.2 | 3.8 | 4.9 | 5.6 | 1.8 | 4.5 | 4.5 | 4.5 | 4.5 | 5.5 | 5.0 | - | - | 0.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | 78.4 | 215.1 | 426.0 | - | 116.5 | 1200.7 | 184.9 | - | 166.9 | 177.7 | 122.8 | - | 166.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | 78.4 | 215.1 | 426.0 | - | 116.5 | 1200.7 | 184.9 | - | 166.9 | 177.7 | 122.8 | - | 166.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | 78.4 | 215.1 | 426.0 | - | 116.5 | 1200.7 | 184.9 | - | 166.9 | 177.7 | 122.8 | - | 166.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency